SG11201502033YA - Pharmaceutical composition comprising rebamipide - Google Patents
Pharmaceutical composition comprising rebamipideInfo
- Publication number
- SG11201502033YA SG11201502033YA SG11201502033YA SG11201502033YA SG11201502033YA SG 11201502033Y A SG11201502033Y A SG 11201502033YA SG 11201502033Y A SG11201502033Y A SG 11201502033YA SG 11201502033Y A SG11201502033Y A SG 11201502033YA SG 11201502033Y A SG11201502033Y A SG 11201502033YA
- Authority
- SG
- Singapore
- Prior art keywords
- rebamipide
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261707386P | 2012-09-28 | 2012-09-28 | |
PCT/JP2013/077011 WO2014051163A1 (en) | 2012-09-28 | 2013-09-27 | Pharmaceutical composition comprising rebamipide |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201502033YA true SG11201502033YA (en) | 2015-04-29 |
Family
ID=49448234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201502033YA SG11201502033YA (en) | 2012-09-28 | 2013-09-27 | Pharmaceutical composition comprising rebamipide |
Country Status (17)
Country | Link |
---|---|
US (1) | US20150246032A1 (en) |
EP (1) | EP2900214A1 (en) |
JP (1) | JP2015531338A (en) |
KR (1) | KR20150063084A (en) |
CN (1) | CN104661650A (en) |
AR (1) | AR092691A1 (en) |
AU (1) | AU2013320866A1 (en) |
BR (1) | BR112015006464A2 (en) |
CA (1) | CA2881374A1 (en) |
EA (1) | EA201590651A1 (en) |
HK (2) | HK1210710A1 (en) |
IL (1) | IL237146A0 (en) |
MX (1) | MX2015004028A (en) |
PH (1) | PH12015500704A1 (en) |
SG (1) | SG11201502033YA (en) |
TW (1) | TW201417814A (en) |
WO (1) | WO2014051163A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170039347A (en) | 2015-10-01 | 2017-04-11 | 삼진제약주식회사 | Novel opthalmic composition comprising rebamipide and method for preparing the same |
KR102307958B1 (en) | 2015-10-01 | 2021-10-05 | 삼진제약주식회사 | Novel opthalmic composition comprising rebamipide and method for preparing the same |
US11324829B2 (en) | 2016-03-14 | 2022-05-10 | Santen Pharmaceutical Co., Ltd. | Antiseptic agent comprising meglumine or salt thereof |
KR101840256B1 (en) * | 2017-09-21 | 2018-03-21 | 대우제약 주식회사 | A water-soluble eye drop composition for the treatment of dry eye syndrome containing rebamipide and its solubilization and stabilization method |
KR101923519B1 (en) * | 2018-06-26 | 2019-02-27 | 대우제약 주식회사 | A water-soluble, multi-use eyedrops composition for the treatment of dry eye syndrome containing rebamipide and a method for solubilization and stabilization thereof |
TW202320815A (en) * | 2021-09-30 | 2023-06-01 | 日商樂敦製藥股份有限公司 | Ophthalmological composition |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101516332B (en) * | 2006-09-21 | 2012-12-19 | 爱尔康研究有限公司 | Self preserved aqueous pharmaceutical compositions |
TWI394564B (en) * | 2006-09-21 | 2013-05-01 | Alcon Res Ltd | Self-preserved aqueous pharmaceutical compositions |
WO2008074853A1 (en) * | 2006-12-21 | 2008-06-26 | Novartis Ag | Ophthalmic rebamipide solution |
RU2538694C2 (en) * | 2008-06-19 | 2015-01-10 | Оцука Фармасьютикал Ко., Лтд. | Pharmaceutical compositions |
US20110052678A1 (en) * | 2010-11-05 | 2011-03-03 | Shantha Totada R | Method for treating age related macular degeneration |
TW201322982A (en) * | 2011-11-01 | 2013-06-16 | Otsuka Pharma Co Ltd | A medicament for treating anterior eye disease comprising rebamipide and a tear-retaining agent |
CN102512420A (en) * | 2011-11-29 | 2012-06-27 | 北京阜康仁生物制药科技有限公司 | Officinal composite using Rebamipide officinal salt as active ingredient |
-
2013
- 2013-09-25 TW TW102134472A patent/TW201417814A/en unknown
- 2013-09-26 AR ARP130103458A patent/AR092691A1/en unknown
- 2013-09-27 AU AU2013320866A patent/AU2013320866A1/en not_active Abandoned
- 2013-09-27 SG SG11201502033YA patent/SG11201502033YA/en unknown
- 2013-09-27 MX MX2015004028A patent/MX2015004028A/en unknown
- 2013-09-27 BR BR112015006464A patent/BR112015006464A2/en not_active IP Right Cessation
- 2013-09-27 CA CA2881374A patent/CA2881374A1/en not_active Abandoned
- 2013-09-27 EP EP13779937.5A patent/EP2900214A1/en not_active Withdrawn
- 2013-09-27 WO PCT/JP2013/077011 patent/WO2014051163A1/en active Application Filing
- 2013-09-27 JP JP2015515329A patent/JP2015531338A/en active Pending
- 2013-09-27 KR KR1020157010337A patent/KR20150063084A/en not_active Application Discontinuation
- 2013-09-27 EA EA201590651A patent/EA201590651A1/en unknown
- 2013-09-27 CN CN201380050716.6A patent/CN104661650A/en active Pending
- 2013-09-27 US US14/431,542 patent/US20150246032A1/en not_active Abandoned
-
2015
- 2015-02-08 IL IL237146A patent/IL237146A0/en unknown
- 2015-03-27 PH PH12015500704A patent/PH12015500704A1/en unknown
- 2015-11-25 HK HK15111582.4A patent/HK1210710A1/en unknown
- 2015-11-25 HK HK15111583.3A patent/HK1210711A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2881374A1 (en) | 2014-04-03 |
BR112015006464A2 (en) | 2017-07-04 |
WO2014051163A1 (en) | 2014-04-03 |
KR20150063084A (en) | 2015-06-08 |
JP2015531338A (en) | 2015-11-02 |
HK1210711A1 (en) | 2016-05-06 |
TW201417814A (en) | 2014-05-16 |
EP2900214A1 (en) | 2015-08-05 |
PH12015500704A1 (en) | 2015-05-25 |
EA201590651A1 (en) | 2015-07-30 |
IL237146A0 (en) | 2015-04-30 |
AU2013320866A1 (en) | 2015-02-26 |
CN104661650A (en) | 2015-05-27 |
MX2015004028A (en) | 2015-07-06 |
US20150246032A1 (en) | 2015-09-03 |
AR092691A1 (en) | 2015-04-29 |
HK1210710A1 (en) | 2016-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201703992B (en) | Inhalable pharmaceutical compositions | |
IL252566A0 (en) | Pharmaceutical compositions and methods | |
HK1209638A1 (en) | Pharmaceutical compositions | |
ZA201501930B (en) | Pharmaceutical composition | |
ZA201501928B (en) | Pharmaceutical antiretroviral composition | |
EP2832730A4 (en) | Mirabegron-containing pharmaceutical composition | |
IL266415A (en) | Novel pharmaceutical composition | |
HK1205146A1 (en) | Pharmaceutical formulation | |
HK1210711A1 (en) | Pharmaceutical composition comprising rebamipide | |
ZA201502987B (en) | Pharmaceutical composition | |
GB201208315D0 (en) | Pharmaceutical methods and compositions | |
EP2897590A4 (en) | Pharmaceutical composition | |
GB201211153D0 (en) | Pharmaceutical compositions | |
EP2851078A4 (en) | Pharmaceutical composition | |
IL238075A0 (en) | Pharmaceutical compositions | |
ZA201400751B (en) | Pharmaceutical composition | |
GB201221130D0 (en) | New pharmaceutical composition | |
GB201207701D0 (en) | New pharmaceutical composition | |
GB201207628D0 (en) | New pharmaceutical composition | |
GB201219234D0 (en) | Pharmaceutical compositions | |
GB201213303D0 (en) | Pharmaceutical compositions | |
GB201204810D0 (en) | Pharmaceutical compositions | |
AU2012904295A0 (en) | Pharmaceutical composition |